agilon health, inc. price to sales ratio AGL

Market value divided by revenue over the last twelve months, since 2022.

Today, Oct 23, 2026: 0.3×
5-year median: 11.7×
Against its 5-year history: 4th; percentile: 0 is its lowest day, 100 its highest
5-year range: 0.2× to 142×
Peer median: 1.3×

agilon health, inc.'s price to sales ratio is 0.3× as of Oct 23, 2026.

That is below its 5-year median of 11.7×, lower than on 96% of days in the last 5 years.

Over that time it ranged from 0.2× in May 2026 to 142× in Apr 2022.

The median for 10 hospital and care facility stocks of a similar size is 1.3×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	0.3×	0.2×	2.1×
2025	1.3×	1.0×	9.7×
2024	3.7×	3.0×	20.9×
2023	30.4×	27.3×	109×
2022	67.0×	67.0×	142×

Against its peers

Companies in Medical - Care Facilities nearest agilon health, inc.'s size, closest first, today.

Company	Price to sales ratio
AGLagilon health, inc.	0.3×
PNTGPennant	1.3×
USPHU S Physical Therapy	1.6×
ARDTArdent Health	0.3×
HCSGHealthcare Services	0.9×
OMDAOmada Health	3.7×
PGNYProgyny	1.7×
ADUSAddus HomeCare	1.5×
MDPediatrix Medical	1.2×
PRVAPrivia Health	1.2×
AVAHAveanna Healthcare	1.1×
Peer median	1.3×

Where agilon health, inc. ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on agilon health, inc.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.